Evidence mapPaperPMID 42425919Full record

ArticleJournal of the American Chemical Society2026

Site-Specific and Programmable Editing of Serine and Threonine in Unprotected Peptides.

Zhenquan Sun, Percy Man-Kit Liao, Adrian Kin Nam Chu, Alvin Wai Leung Lam, Yaoyue Zhang, Jie Yu, Xuechen Li

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhenquan SunDepartment of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, Hong Kong SAR 999077, P. R. China.ORCID 0000-0003-0877-9015
Percy Man-Kit LiaoDepartment of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, Hong Kong SAR 999077, P. R. China.
Adrian Kin Nam ChuDepartment of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, Hong Kong SAR 999077, P. R. China.
Alvin Wai Leung LamDepartment of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, Hong Kong SAR 999077, P. R. China.
Yaoyue ZhangDepartment of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, Hong Kong SAR 999077, P. R. China.
Jie YuDepartment of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, Hong Kong SAR 999077, P. R. China.
Xuechen LiDepartment of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, Hong Kong SAR 999077, P. R. China.ORCID 0000-0001-5465-7727

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serine and threonine residues dominate regulatory post-translational modifications in nature, yet remain largely inaccessible to programmable chemical editing. Their weak hydroxyl nucleophilicity and the presence of multiple indistinguishable sites within proteins have prevented the development of general, site-selective strategies for modification in unprotected polypeptides. Here, we report that aminooxy serine or aminooxy threonine can mediate an effective aminooxy ligation (AOL) in aqueous solution through a transient 1,2,4-oxadiazinane intermediate, enabling chemoselective peptide ligation at the N-terminal position. Furthermore, the embedded aminooxy functionality after AOL subsequently undergoes a chemoselective ester ligation (CEL) with keto acids to restore aminooxy into native Ser/Thr and install O-acylation. This two-stage strategy offers site-specific Ser/Thr modification under mild conditions, permitting reductive restoration, neoglycosylation, or O-acylation. Applications range from late-stage modification of therapeutic peptide analogues to the convergent chemical synthesis of histone H2B bearing site-specific O-neoglycosylation and O-acylation. Together, this work establishes a general chemical framework for serine and threonine editing for protein chemical synthesis and engineering.

Indexed as

PeptidesSerineThreonineAcylationPeptidesSerineThreonine

Identifiers

PMID42425919
PMCPMC13397880

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.